We have compiled a list of manufacturers, distributors, product information, reference prices, and rankings for medicine.
ipros is IPROS GMS ・ IPROS One of the largest technical database sites in Japan that collects information on.

medicine Product List and Ranking from 32 Manufacturers, Suppliers and Companies

Last Updated： Aggregation Period:Oct 01, 2025～Oct 28, 2025
This ranking is based on the number of page views on our site.

medicine Manufacturer, Suppliers and Company Rankings

Last Updated： Aggregation Period:Oct 01, 2025～Oct 28, 2025
This ranking is based on the number of page views on our site.

  1. マーケットリサーチセンター Tokyo//Service Industry
  2. スペラファーマ Osaka//others
  3. null/null
  4. 4 立山化成 Toyama//Manufacturing and processing contract
  5. 5 関東化学株式会社 バイオケミカル部 Tokyo//Chemical
Go to Company Ranking

medicine Product ranking

Last Updated： Aggregation Period:Oct 01, 2025～Oct 28, 2025
This ranking is based on the number of page views on our site.

  1. Contract development and manufacturing (CDMO) business for mid-sized molecules (oligonucleotides and peptides) active pharmaceutical ingredients.
  2. For various titrations! The titration "indicator" specified in JIS K8001. 関東化学株式会社 バイオケミカル部
  3. Tateyama Kasei Co., Ltd. Kyushu Factory 立山化成
  4. Cavity prevention medicine Gurupepr カツマタ 医薬品製造販売部
  5. 4 [Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments マーケットリサーチセンター

medicine Product List

331～345 item / All 590 items

Displayed results
[Research Material] Global Market for Eosinophilia Syndrome Drugs

[Research Material] Global Market for Eosinophilia Syndrome Drugs

Eosinophilia syndrome drugs global market: Benralizumab, Dasatinib, Dexmethylphenidate hydrochloride, Mepolizumab, Others, Research centers ...

This research report (Global Hypereosinophilic Syndrome Drug Market) investigates and analyzes the current state and outlook for the global market of eosinophilia syndrome drugs over the next five years. It includes information on the overview of the global eosinophilia syndrome drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Benralizumab, Dasatinib, Dexamethasone, Mepolizumab, and others, while the segments by application focus on research centers, hospitals, and clinics. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for eosinophilia syndrome drugs. It also includes the market share of major companies in the eosinophilia syndrome drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for CRISPR-Based Therapies

[Research Material] Global Market for CRISPR-Based Therapies

Global Market for CRISPR-Based Therapies: Genome Editing, Genetic Engineering, gRNA Databases/Gene Libraries, CRISPR Plus ...

This research report (Global CRISPR-Based Therapeutics Market) investigates and analyzes the current state and future outlook of the global market for CRISPR-based therapies over the next five years. It includes information on the overview of the global CRISPR-based therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the CRISPR-based therapeutics market include genome editing, genetic engineering, gRNA databases/gene libraries, CRISPR plasmids, human stem cells, genetically modified organisms/crops, and cell line engineering. The segments by application target biotechnology companies, pharmaceutical companies, academic institutions, and research and development organizations. The regional segments calculate the market size for CRISPR-based therapies by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. The report also includes the market share of major companies in CRISPR-based therapies, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Dyslipidemia Treatment

[Research Material] The Global Market for Dyslipidemia Treatment

World Market for Dyslipidemia Treatment: Atorvastatin, Fluvastatin, Rosuvastatin, Simvastatin, Pravastatin, Other Drugs, ...

This research report (Global Lipid Disorder Treatment Market) investigates and analyzes the current state and outlook for the global lipid disorder treatment market over the next five years. It includes information on the overview of the global lipid disorder treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include atorvastatin, fluvastatin, rosuvastatin, simvastatin, pravastatin, and other drugs, while the segments by application focus on hospitals, clinics, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for lipid disorder treatment. It also includes the market share of major companies in lipid disorder treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments

[Research Material] The Global Market for Neglected Tropical Disease (NTD) Treatments

Global Market for Neglected Tropical Disease (NTD) Treatment: Therapeutics, Vaccines, Hospitals & Clinics, Diagnostic Centers, Academic & Research Institutions

This research report (Global Neglected Tropical Disease (NTD) Treatment) investigates and analyzes the current state and outlook for the global market for neglected tropical disease (NTD) treatment over the next five years. It includes information on the overview of the global neglected tropical disease (NTD) treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the neglected tropical disease (NTD) treatment market focus on therapeutic drugs and vaccines, while the segments by application target hospitals and clinics, diagnostic centers, and academic and research institutions. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for neglected tropical disease (NTD) treatment. It also includes the market share of major companies in neglected tropical disease (NTD) treatment, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Anticoagulant Therapy

[Research Material] The Global Market for Anticoagulant Therapy

Global Market for Anticoagulant Therapy: NOACs, Warfarin, In-Hospital Clinics, Independent Clinics, Pharmacy-Based Clinics

This research report (Global Anticoagulation Therapy Market) investigates and analyzes the current state of the global anticoagulation therapy market and its outlook for the next five years. It includes information on the overview of the global anticoagulation therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anticoagulation therapy market focus on NOAC and warfarin, while the segments by application target inpatient clinics, independent clinics, and pharmacy-based clinics. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size of anticoagulation therapy. It also includes the market share of major companies in anticoagulation therapy, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Anti-Infective Therapy

[Research Material] Global Market for Anti-Infective Therapy

World Market for Antimicrobial Therapy: Penicillin, Sulfonamides, Aminoglycosides, Fluoroquinolones, Antifungals, Antiprotozoals, Others, Household...

This research report (Global Anti-Infective Therapy Market) investigates and analyzes the current status and outlook for the global anti-infective therapy market over the next five years. It includes information on the overview of the global anti-infective therapy market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anti-infective therapy market include penicillin, sulfonamides, aminoglycosides, fluoroquinolones, antifungals, antiprotozoals, and others, while the segments by application cover home use, hospitals/clinics, outpatient surgery centers, and others. The regional segments are divided into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for anti-infective therapy. It also includes the market share of major companies in anti-infective therapy, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Antidiabetic Drugs

[Research Material] Global Market for Antidiabetic Drugs

Global Market for Antidiabetic Drugs: Biguanides, Sulfonylureas, Meglitinides, Thiazolidinediones, Dipeptidyl Peptidase IV Inhibitors ...

This research report (Global Anti-Diabetic Drugs Market) investigates and analyzes the current state and outlook for the global market of anti-diabetic drugs over the next five years. It includes information on the overview of the global anti-diabetic drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the anti-diabetic drug market include biguanides, sulfonylureas, meglitinides, thiazolidinediones, dipeptidyl peptidase IV inhibitors, and alpha-glucosidase inhibitors, while the segments by application focus on Type 1 diabetes, Type 2 diabetes, and others. The regional segments calculate the market size of anti-diabetic drugs by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the anti-diabetic drug sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hemorrhagic Stroke Treatment Drugs

[Research Material] Global Market for Hemorrhagic Stroke Treatment Drugs

World Market for Hemorrhagic Stroke Treatment Drugs: Antihypertensives, Anticoagulants, Diuretics, Anticonvulsants, Others, Hospitals, Clinics, Others

This research report (Global Haemorrhagic Stroke Drugs Market) investigates and analyzes the current status and outlook for the global market of hemorrhagic stroke treatment drugs over the next five years. It includes information on the overview of the global hemorrhagic stroke treatment drug market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antihypertensives, anticoagulants, diuretics, anticonvulsants, and others, while the segments by application focus on hospitals, clinics, and others. The regional segments are classified into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for hemorrhagic stroke treatment drugs. It also includes the market share of major companies in the hemorrhagic stroke treatment drug market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Treatments of Retinopathy of Prematurity

[Research Material] Global Market for Treatments of Retinopathy of Prematurity

World Market for Treatments of Retinopathy of Prematurity: IB-09A0133, Mecasermin Rinfabate, Propranolol, R-200, Others, Disease ...

This research report (Global Retinopathy Of Prematurity Therapeutics Mar) investigates and analyzes the current state and future outlook of the global market for therapeutics for retinopathy of prematurity. It includes information on the overview of the global market for retinopathy of prematurity therapeutics, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the retinopathy of prematurity therapeutics market include IB-09A0133, Mecelsamin Linfabet, Propranolol, R-200, and others, while the segments by application focus on hospitals, clinics, and home healthcare. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for retinopathy of prematurity therapeutics. It also includes the market share of major companies in the retinopathy of prematurity therapeutics market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Hemophilia A and B Treatment Materials

[Research Material] Global Market for Hemophilia A and B Treatment Materials

World Market for Hemophilia A and B Treatment Materials: Desmopressin, Octocog alfa, Nonacog alfa, Others, Dental Clinics, Hospitals, Outpatient Surgery Centers

This research report (Global Hemophilia A and B Therapeutics Materials) investigates and analyzes the current state of the global market for hemophilia A and B therapeutic materials and its outlook for the next five years. It includes information on the global hemophilia A and B therapeutic materials market overview, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include Desmopressin, Octocog alfa, Nonacog alfa, and others, while the segments by application focus on dental clinics, hospitals, and outpatient surgical centers. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for hemophilia A and B therapeutic materials. It also includes the market share of major companies in the hemophilia A and B therapeutic materials market, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Sinusitis Treatment Drugs

[Research Material] Global Market for Sinusitis Treatment Drugs

World Market for Sinusitis Treatment Drugs: Antibiotics, NSAIDs, Decongestants and Mucolytics, Nasal Irrigation Kits, Hospitals, Clinics, Others

This research report (Global Sinusitis Treatment Drugs Market) investigates and analyzes the current status and outlook for the global market for sinusitis treatment drugs over the next five years. It includes information on the overview of the global sinusitis treatment drugs market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include antibiotics, NSAIDs, decongestants and mucolytics, and nasal irrigation kits, while the segments by application focus on hospitals, clinics, and others. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa to calculate the market size for sinusitis treatment drugs. It also includes the market share of major companies in the sinusitis treatment drugs sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for Multiple Sclerosis Drug Treatment

[Research Material] Global Market for Multiple Sclerosis Drug Treatment

Global Market for Multiple Sclerosis Drug Treatment: Interferons, Immunomodulators, Immunosuppressants, Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others

This research report (Global Multiple Sclerosis Drugs Treatment Market) investigates and analyzes the current status and outlook for the global market for multiple sclerosis drug treatment over the next five years. It includes information on the overview of the global multiple sclerosis drug treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include interferons, immunomodulators, and immunosuppressants, while the segments by application focus on hospital pharmacies, retail pharmacies, online pharmacies, and others. The regional segments calculate the market size for multiple sclerosis drug treatment by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the multiple sclerosis drug treatment sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Treatment of Neurofibromatosis Type II

[Research Material] The Global Market for Treatment of Neurofibromatosis Type II

World Market for Treatment of Neurofibromatosis Type II: AR-42, FRAX-597, Icotinib Hydrochloride, LB-201, LB-205, Others, Cre...

This research report (Global Neurofibromatoses Type II Therapeutics Market) investigates and analyzes the current state and outlook for the global market for Neurofibromatosis Type II treatments over the next five years. It includes information on the overview of the global Neurofibromatosis Type II treatment market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments for Neurofibromatosis Type II treatments by type include AR-42, FRAX-597, Icotinib Hydrochloride, LB-201, LB-205, and others, while the segments by application focus on clinics, hospitals, and home care. The regional segments are categorized into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa, to calculate the market size for Neurofibromatosis Type II treatments. The report also includes the market share of major companies in Neurofibromatosis Type II treatments, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] Global Market for CNS Therapeutics

[Research Material] Global Market for CNS Therapeutics

Global Market for CNS Therapeutics: Neurodegenerative Diseases, Mood Disorders, Schizophrenia, Autism, Depression, Hospitals, Clinics, Home, Others

This research report (Global CNS Therapeutics Market) investigates and analyzes the current state and outlook for the global CNS therapeutics market over the next five years. It includes information on the overview of the global CNS therapeutics market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The segments by type in the CNS therapeutics market focus on neurodegenerative diseases, mood disorders, schizophrenia, autism, and depression, while the segments by application target hospitals, clinics, home care, and others. The regional segments calculate the market size of CNS therapeutics by dividing it into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in CNS therapeutics, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration
[Research Material] The Global Market for Immunosuppressive Drugs for Organ Transplantation

[Research Material] The Global Market for Immunosuppressive Drugs for Organ Transplantation

World Market for Immunosuppressive Drugs for Organ Transplantation: Tacrolimus, Mycophenolate Mofetil, Cyclosporine, Others, Liver Transplantation, Kidney Transplantation, Heart ...

This research report (Global Organ Transplant Immunosuppressant Market) investigates and analyzes the current status and outlook for the global market of immunosuppressants for organ transplantation over the next five years. It includes information on the overview of the global organ transplant immunosuppressant market, trends of major companies (sales, selling prices, market share), market size by segment, market size by major regions, and distribution channel analysis. The market segments by type include tacrolimus, mycophenolate mofetil, cyclosporine, and others, while the segments by application cover liver transplant, kidney transplant, heart transplant, and others. The regional segments calculate the market size of organ transplant immunosuppressants by dividing them into North America, the United States, Europe, Asia-Pacific, Japan, China, India, South Korea, Southeast Asia, South America, the Middle East, and Africa. It also includes the market share of major companies in the organ transplant immunosuppressant sector, product and business overviews, and sales performance.

  • Other services

Added to bookmarks

Bookmarks list

Bookmark has been removed

Bookmarks list

You can't add any more bookmarks

By registering as a member, you can increase the number of bookmarks you can save and organize them with labels.

Free membership registration

Search Keywords Related to medicine

COPYRIGHT © 2001-2025 IPROS CORPORATION ALL RIGHTS RESERVED.